COMMUNIQUÉS West-GlobeNewswire

Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”
04/05/2026
HALIFAX, Nova Scotia, May 04, 2026 (GLOBE NEWSWIRE) -- To mark World Ovarian Cancer Day, Ovarian Cancer Canada is announcing a $725,000 investment to fuel critical ovarian cancer research. Led by globally respected [...]
Orion Corporation: Managers’ transactions – Henrik Stenqvist
04/05/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MAY 2026 at 16.00 EEST Orion Corporation: Managers’ transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
04/05/2026
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)- [...]
Orion Corporation: Managers’ transactions – Kari Jussi Aho
04/05/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MAY 2026 at 16.00 EEST Orion Corporation: Managers’ transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
04/05/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MAY 2026 at 16.00 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers’ transactions – Minna Maasilta
04/05/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MAY 2026 at 16.00 EEST Orion Corporation: Managers’ transactions – Minna Maasilta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps
04/05/2026
Seasonal pollen doesn't just trigger sneezing. It compounds respiratory stress in ways most allergy sufferers don't expect. Austin, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Spring Allergies Hit Lungs Hard — Pharmacist [...]
Orion Corporation: Managers’ transactions – Hilpi Rautelin
04/05/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MAY 2026 at 16.00 EEST Orion Corporation: Managers’ transactions – Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Curated Digital Health Works; Now There’s a Claims Study to Prove It
04/05/2026
Independent validation of a large U.S. health plan’s claims data shows $1,241 in per-member savings, a $2.42 return on every dollar invested, and meaningful reduction in high-cost utilization PHOENIX, May 04, 2026 ( [...]
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
04/05/2026
FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway” for CNM-Au8 based on neurofilament light (NfL) biomarker data FDA [...]
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
04/05/2026
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, [...]
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
04/05/2026
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to [...]
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
04/05/2026
Oral presentation includes early readouts from preclinical testing of CAR-encoding episomal DNA delivered by targeted lipid nanoparticles CPTx will present two posters at ASGCT 2026 Munich, Germany — May 4, 2026 — CPTx [...]
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
04/05/2026
Jeremy B. Fitch, MBA, appointed as Chief Business Officer Michael A. Alrutz, J.D., Ph.D., appointed as General Counsel Guy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United Kingdom and NEW YORK, [...]
Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1
04/05/2026
Data presented at IWGGD 2026 Symposium show a meaningful reduction in bone marrow burden with improvements in bone density LONDON, May 04, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today released new data from the [...]
4DMT to Participate in Upcoming Investor Conferences
04/05/2026
EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
04/05/2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies [...]
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society
04/05/2026
-- Pediatric patients (n=10) with acquired hypothalamic obesity achieved sustained reductions in BMI and BMI-Z at 2.5 years of setmelanotide therapy -- -- Weight category improvements observed in pediatric patients with [...]
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
04/05/2026
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, [...]

Pages